Brian Nowosielski

Among rural community pharmacies in the US, researchers explored pneumococcal immunization services, the processes used to identify patient eligibility, and the barriers to vaccine administration.

Researchers conducted a systematic review to determine the effectiveness of pharmacists in promoting vaccine uptake for protection against the most prominent infectious diseases.

After the certification of a new stroke center in respective communities, researchers compared the stroke outcomes of Black patients with those of White patients.

Hashim Zaibak, PharmD, CEO of Hayat Pharmacy, discusses the ongoing narratives surrounding vaccine hesitancy as well as his thoughts on the best ways of addressing the phenomenon.

When independent and retail storefronts close across the country, creating a lack of pharmacy services in the community, pharmacy deserts arise.

In this retrospective cohort study, researchers investigated the association between formulary coverage for disease-modifying therapies and the potential for MS relapse.

Hashim Zaibak, PharmD, CEO of Hayat Pharmacy, discusses how immunization services at his pharmacy locations have evolved since the COVID-19 pandemic.

Researchers explore whether or not exposure to e-cigarette or cannabis content on social media leads to increased use among adolescents.

For biosimilar, generic, and branded medications, Cencora researchers conducted a report detailing growth in formulary exclusions among the 3 largest pharmacy benefit managers in the US.

Researchers in Kenya explored vaccination behaviors among individuals of various socioeconomic or educational statuses.

Michael Murphy, PharmD, MBA, discusses the increasingly prominent impacts of pharmacy deserts, highlighting discrepancies in the term's definition and the financial pressures impacting sustainability.

Among pediatric patients in Colombia, researchers explored the prevalence of bacterial acute otitis media caused by Streptococcus pneumoniae.

JD Power released its 2025 US Pharmacy Study detailing customer satisfaction with brick-and-mortar, mail order, supermarket, and mass-market retail pharmacies.

Researchers explore factors influencing pharmacists' willingness to provide medication takeback services, highlighting the need for improved disposal practices and education.

Community pharmacists embrace mental health interventions to combat depression and anxiety in long-term condition patients, enhancing overall care and accessibility.

With expertise into the growing issue of pharmacy deserts, Michael Murphy, PharmD, MBA, discussed exactly what patients are losing when their community no longer has pharmacy access.

Among patients with cirrhosis receiving diuretic therapy, researchers explore the association between SGLT-2 inhibitors and the risk of serious liver outcomes.

Michael Murphy, PharmD, MBA, joined Drug Topics to present his ideas for correcting the growing issue of pharmacy deserts and unprecedented closures across the country.

Senators Warner and Thune reintroduced the ECAPS legislation improving both seniors’ access to care and pharmacists’ ability to get reimbursed for clinical services.

Researchers explored how the GLP-1 medications semaglutide and tirzepatide impact incidence rates in a variety of health-related outcomes.

With the company’s dedication to providing crucial data for pharmacy stakeholders, IQVIA’s Lead Research Director Michael Kleinrock discussed the current trends in patients’ medication use.

LEO Pharma’s topical medication was shown to be safe and effective in adult patients with moderate-to-severe hand eczema.

Amid uncertainty about the best factors for measuring and defining pharmacy deserts, researchers explored the impacts of drive time and inequities in pharmacy access.

Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.

With an emphasis on the factors that differentiate the future roles of pharmacists, researchers sought to better understand the career intentions of pharmacy students.

In part 4 of our interview with Michael Kleinrock, lead director of research at IQVIA, he discussed how trends in medication use are currently impacting pharmacy businesses.

Michael Murphy, PharmD, MBA, discusses how the lack of a universal definition for pharmacy deserts is leading to a significant impact on patients’ access and outcomes.

Using the Q Methodology to account for subjectivity in responses, pharmacists self-identified their professional identities.

In the researchers’ exploration of post-ICU nutritional care, they detailed the clinical pharmacist’s role and provided insights into how this role may evolve in the future.

Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.